Global Radiation Oncology Market 2017-2021

  • ID: 4403346
  • Report
  • Region: Global
  • 97 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Accuray
  • Carl Zeiss Meditec
  • IBA Worldwide
  • IsoRay
  • Nordion
  • Toshiba Medical Systems
  • MORE
About Radiation Oncology

Radiation treatment, which is also called radiotherapy, irradiation, or X-ray therapy, is one of the most common treatments for cancer. It uses high-energy particles or waves such as X-rays, gamma rays, electron beams, or protons to destroy or damage cancer cells. More than half of all people with cancer are treated with radiation therapy. Radiation therapy can be administered through EBRT or brachytherapy. EBRT delivers high-energy rays or beams from outside the body into the tumor. The beams are generated outside the patient, generally by a linear accelerator (LINAC), and targeted at the tumor site.

The analysts forecast the global radiation oncology market to grow at a CAGR of 5.29% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global radiation oncology market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Radiation Oncology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
  • Accuray
  • C. R. Bard
  • Elekta
  • IBA Worldwide
  • Varian Medical Systems
Other prominent vendors
  • Carl Zeiss Meditec
  • iCAD
  • IsoRay
  • Mevion Medical Systems
  • Nordion
  • NTP Radioisotopes
  • Toshiba Medical Systems
Market drivers
  • Increasing incidence of cancer
  • For a full, detailed list, view the full report
Market challenges
  • Lack of access to radiotherapy
  • For a full, detailed list, view the full report
Market trends
  • Strategic collaborations and M&A
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Accuray
  • Carl Zeiss Meditec
  • IBA Worldwide
  • IsoRay
  • Nordion
  • Toshiba Medical Systems
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Overview
  • Market size and forecast
  • Five forces analysis
PART 06: Segmentation by product type
  • Overview
  • EBRT
  • Brachytherapy
PART 07: Segmentation by geography
  • Overview
  • Americas
  • EMEA
  • APAC
PART 08: Decision framework

PART 09: Drivers and challenges
  • Market drivers
  • Market challenges
PART 10: Market trends
  • Strategic collaborations and M&A
  • Increasing demand for proton therapy
PART 11: Vendor landscape
  • Competitive landscape
PART 12: Key vendor analysis
  • Accuray
  • C. R. Bard
  • Elekta
  • IBA Worldwide
  • Varian Medical Systems
  • Other prominent vendors
PART 13: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global radiation oncology market: Segmentation
Exhibit 02: Global radiation oncology market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global radiation oncology market: Segmentation by product type 2016 (% share)
Exhibit 05: Global EBRT market 2016-2021 ($ millions)
Exhibit 06: Global EBRT market: Segmentation by product type
Exhibit 07: Major LINACs
Exhibit 08: Global LINAC market 2016-2021 ($ millions)
Exhibit 09: Major compact advanced radiotherapy systems
Exhibit 10: Global compact advanced radiotherapy systems market 2016-2021 ($ millions)
Exhibit 11: Global compact advanced radiotherapy systems market: Segmentation by product type 2016 (% share)
Exhibit 12: Major proton therapy systems
Exhibit 13: Global proton therapy systems market 2016-2021 ($ millions)
Exhibit 14: Global brachytherapy market 2016-2021 ($ millions)
Exhibit 15: Major brachytherapy seeds, applicators, and after loaders
Exhibit 16: Global brachytherapy seeds, applicators, and after loaders market 2016-2021 ($ millions)
Exhibit 17: Major electronic brachytherapy systems
Exhibit 18: Global electronic brachytherapy market 2016-2021 ($ millions)
Exhibit 19: Global radiation oncology market: Segmentation by geography 2016 (% share)
Exhibit 20: Radiation oncology market in Americas 2016-2021 ($ millions)
Exhibit 21: Radiation oncology market in EMEA 2016-2021 ($ millions)
Exhibit 22: Radiation oncology market in APAC 2016-2021 ($ millions)
Exhibit 23: Radiotherapy equipment available per 1,000,000 people in healthcare facilities 2013 and 2015
Exhibit 24: Global radiation oncology market: Competitive structure analysis 2016
Exhibit 25: Accuray: Key highlights
Exhibit 26: Accuray: Strength assessment
Exhibit 27: Accuray: Strategy assessment
Exhibit 28: Accuray: Opportunity assessment
Exhibit 29: C. R. Bard: Key highlights
Exhibit 30: C. R. Bard: Strength assessment
Exhibit 31: C. R. Bard: Strategy assessment
Exhibit 32: C. R. Bard: Opportunity assessment
Exhibit 33: Elekta: Key highlights
Exhibit 34: Elekta: Strength assessment
Exhibit 35: Elekta: Strategy assessment
Exhibit 36: Elekta: Opportunity assessment
Exhibit 37: IBA Worldwide: Key highlights
Exhibit 38: IBA Worldwide: Strength assessment
Exhibit 39: IBA Worldwide: Strategy assessment
Exhibit 40: IBA Worldwide: Opportunity assessment
Exhibit 41: Varian Medical Systems: Key highlights
Exhibit 42: Varian Medical Systems: Strength assessment
Exhibit 43: Varian Medical Systems: Strategy assessment
Exhibit 44: Varian Medical Systems: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Accuray
  • Carl Zeiss Meditec
  • IBA Worldwide
  • IsoRay
  • Nordion
  • Toshiba Medical Systems
  • MORE
New Report Released: – Global Radiation Oncology Market 2017-2021

The author of the report recognizes the following companies as the key players in the global radiation oncology market: Accuray, C. R. Bard, Elekta, IBA Worldwide, and Varian Medical Systems.

Other Prominent Vendors in the market are: Carl Zeiss Meditec, iCAD, IsoRay, Mevion Medical Systems, Nordion, NTP Radioisotopes, and Toshiba Medical Systems.

Commenting on the report, an analyst from the research team said: “One trend in the market is strategic collaborations and M&A. Strategic M&A and collaborations are becoming common in the global radiation oncology market. Key vendors are pursuing M&A to strengthen their market positions and expand their product portfolios. Many vendors are also collaborating with other vendors to expand their market presence.”

According to the report, one driver in the market is increasing incidence of cancer. The incidence of cancers such as lung, breast, prostate, colorectal, and stomach is increasing. In 2012, the global incidence of cancer was approximately two million for billion people. In 2015, the global mortality from cancer was approximately 1,200 for million people. Lung cancer is the most common cancer across the world. In 2012, the global incidence of lung cancer was approximately 250,000 for billion people. Breast cancer is the second most common cancer across the world. In 2012, the global incidence of breast cancer was approximately 240,000 for billion people.

Further, the report states that one challenge in the market is lack of access to radiotherapy. There is a lack of access to radiotherapy due to shortage in investments. Low healthcare expenditure, shortage of equipment, and shortage of trained staff and facilities have resulted in the low adoption of radiation equipment. There is a global shortage of radiotherapy services, with more than 90% of all cancer patients in low-income countries lacking access to radiotherapy. Most installed LINACs are in high-income countries. The global standard for cancer care requires that one radiation megavoltage machine for an average of 150,000 people living in the region. However, many countries in Africa have no radiotherapy equipment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Accuray
  • C. R. Bard
  • Elekta
  • IBA Worldwide
  • Varian Medical Systems
  • Carl Zeiss Meditec
  • iCAD
  • IsoRay
  • Mevion Medical Systems
  • Nordion
  • NTP Radioisotopes
  • Toshiba Medical Systems
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll